Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt

Author

Satoshi Honda

View on Semantic Scholar

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Lipidic Plaque Features of Polyvascular Disease in Response to Low-Density Lipoprotein Cholesterol <55 mg/dL: Implication of Circulating Lipoprotein(a) Levels.

Coronary atheroma in patients with PolyVD was resistant to lowering LDL-C <55 mg/dL, and lipoprotein(a) may be a potential therapeutic target to delipidate coronary atheroma.

A. Katasako-Yabumoto, Yu Kataoka, S. Nicholls et al. · 0 citations
Open access Sep 2026

SMuRF-less ST-segment elevation myocardial infarction in contemporary Japanese practice: Clinical characteristics and prognostic implications from the Japan acute myocardial infarction registry

Background Standard modifiable cardiovascular risk factor (SMuRF)-less myocardial infarction, defined as the absence of diabetes, dyslipidemia, hypertension, and smoking, may have different clinical implications in East Asian patients because coronary pathophysiology and preventive treatment patterns differ from those...

K. Wayama, J. Takahashi, Satoshi Honda et al. · 0 citations
Open access Sep 2026

Impact of Right Ventricular Involvement on Bleeding and Mortality in Patients With Right Coronary Artery-Related Myocardial Infarction　- Insights From Nationwide Registry.

BACKGROUND Right ventricular involvement (RVI) in acute myocardial infarction (AMI) patients is recognized as a high-risk subset. However, its impact on bleeding and mortality is not well defined in patients with right coronary artery (RCA)-related ST-segment elevation acute myocardial infarction (STEMI) undergoing per...

Satoshi Honda, K. Nishihira, M. Takegami et al. · 0 citations
Meta-analysis Sep 2026

Ultrashort vs Standard-Duration Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing PCI: A Meta-Analysis.

BACKGROUND The efficacy and safety of ultrashort (≤1-month) dual antiplatelet therapy (DAPT) followed by antiplatelet monotherapy remain uncertain in acute coronary syndrome (ACS) patients. OBJECTIVES This study sought to compare ultrashort vs standard-duration DAPT in patients with ACS undergoing percutaneous corona...

Hendrianus Hendrianus, Diana A Gorog, U. Tantry et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.